Clinical trial
Efficacy and Safety of Rupatadine 10 and 20 Mg in Chronic Idiopathic Urticaria
NCT00199251 · J. Uriach and Company, Industry · Terminated
Key facts
| NCT number | NCT00199251 |
|---|---|
| Title | Efficacy and Safety of Rupatadine 10 and 20 Mg in Chronic Idiopathic Urticaria |
| Official title | A 6-Week Multicentre, Double-Blind, Randomised, Placebo-Controlled, Parallel-Group Study to Assess the Efficacy and Safety of Rupatadine 10 and 20 Mg in the Treatment of Chronic Idiopathic Urticaria (CIU): a Phase III Clinical Trial |
| Lead sponsor | J. Uriach and Company, Industry |
| Status | Terminated |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Urticaria |
| Intervention type | Drug |
| Interventions | RUPATADINE |
| Enrollment | 300 |
| Start date | Apr 1, 2004 |
| Completion | Jun 1, 2005 |
| First posted | Sep 20, 2005 |
| Last update posted | Dec 23, 2005 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: